Results 121 to 130 of about 14,183,490 (208)

Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer. [PDF]

CPT Pharmacometrics Syst Pharmacol
Franzese RC, Qin L, Fu S, Rich B, Zografos E, Zierhut ML, Visser SAG.   +6 more
europepmc   +1 more source

The Response of Market Interest Rates to Discount Rate Changes [PDF]

Review, 1992
openaire   +2 more sources

Utility of PROM Questionnaires: Correlation of Question Burden and Response Rate Among Surgically Treated Patients with Musculoskeletal Diseases. [PDF]

J Clin Med
Vilkki K, Äärimaa V, Meronen S, Kostensalo J, Taskinen HS, Rantalaiho I, Ryösä A, Pernaa K, Laaksonen I.   +8 more
europepmc   +1 more source

HOW TO REACH 70% RESPONSE RATE IN THE NATIONAL BREAST CANCER SCREENING PROGRAM IN CROATIA? [PDF]

Acta Clin Croat
Kovačević J, Musil V, Sović S, Zombori D, Jureša V.   +4 more
europepmc   +1 more source

Quantifying partial pathological response rate in prostate cancer patients who underwent neoadjuvant chemotherapy using a novel morphometric approach. [PDF]

J Pathol Inform
Huang W, Li H, Tsourkas P, Mcilwain S, Ong I, Kyriakopoulos CE, Johnson B, Cho SY, Wells SA, Alzate AR, Jarrard DF, Heninger E, Lang JM.   +12 more
europepmc   +1 more source

Real-World Outcomes of Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma: Analyzing Patient-Specific Factors Influencing Survival and Response Rate. [PDF]

Cancer Rep (Hoboken)
Huber L, Kohler C, Lammert A, Scherl C, Ludwig S, Affolter A, Rotter N, Jungbauer F.   +7 more
europepmc   +1 more source

The Relationship Between Response Rate and Survival Benefits in Randomized Immunotherapy Studies. [PDF]

Cancers (Basel)
Jain A, Stebbing J.
europepmc   +1 more source

Association of ctDNA <i>RAS</i> mutational status and clinical benefits in first-line metastatic colorectal cancer therapy with chemotherapy plus anti-EGFR (overall response rate and progression-free survival): a brief report of systematic review and meta-analysis. [PDF]

J Gastrointest Oncol
Valladares-Ayerbes M, García Alfonso P, Heinemann V, Manca P, Stintzing S, Pietrantonio F, Montagut C, Safont Aguilera MJ, Maurel J, González Flores E, Vidal J, Formica V, Sabaté-Pina M, Alfonso-González V, Prat-Llorens G.   +14 more
europepmc   +1 more source

The Impact of the Rs1044457 Polymorphism in the CMPK1 Gene on the Response Rate to Gemcitabine-Based Chemotherapy in Metastatic NSCLC Patients. [PDF]

Adv Genet (Hoboken)
Saleh GS, Gatea FK, Al-Mayah QS, Lazim H.   +3 more
europepmc   +1 more source

Event-free survival and complete response rate as surrogate endpoints for overall survival in high-risk non-muscle-invasive bladder cancer: A meta-analysis of bacillus Calmette-Guérin-naive or -remote cases. [PDF]

Cancer
Bhattacharya R, Kponee-Shovein K, Gao Y, Song Y, Liu J, Wei K, Kapadia E, Li H, Kamat AM.   +8 more
europepmc   +1 more source